Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBIRI for Unresectable Liver Metastases From Colorectal Cancer
NCT03175016Phase 3Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jun 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irinotecan in colorectal cancer (CRC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Status: unknown.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03175016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03175016.